We did a global review to synthesise data on the prevalence, harms, and interventions for
stimulant use, focusing specifically on the use of cocaine and amphetamines. Modelling …

Background: On the current psychopharmacological panorama, the variety of substances
able to provoke an episode of acute psychosis is rapidly increasing. Such psychotic …

Methamphetamine is a potent psychostimulant that can induce psychosis among
recreational and chronic users, with some users develo** a persistent psychotic syndrome …

Robust epidemiological evidence of risk and protective factors for psychosis is essential to
inform preventive interventions. Previous evidence syntheses have classified these risk and …

Background The clinical profiles of methamphetamine-induced psychosis (MIP) and
schizophrenia are largely overlap** making differentiation challenging. In this systematic …

Background The “trimorbidity” of substance use disorder and mental and physical illness is
associated with living in precarious housing or homelessness. The extent to which …

Background Stimulant prescriptions increased by 250% in the United States from 2006-2016
while diagnoses for ADHD minimally increased. There is insufficient data regarding who …

Objectives: The psychiatric symptom profile of methamphetamine-associated psychosis
(MAP) has varied considerably across studies of different research designs. We performed a …

Introduction Methamphetamine associated psychosis (MAP) represents a mental disorder
induced by chronic methamphetamine use in a subset of users. The prevalence of the …

Substance-induced psychosis is a secondary psychotic disorder resulting from drug abuse,
characterized by one or more psychotic episodes. Drug-induced psychosis is expected to …